EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains—phenotypic, genetic and reference genome characterization

Magnus Unemo iD, Leonor Sánchez-Busó, Daniel Golparian, Susanne Jacobsson, Ken Shimuta, Pham Thi Lan, David W Eyre, Michelle Cole, Ismael Maatouk iD, Teodora Wi, Monica M Lahra

Journal of Antimicrobial Chemotherapy · 2024

DOI: 10.1093/jac/dkae176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Magnus Unemo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Faculty of Medicine and Health, WHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laborat…. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Genome, Bacterial, Anti-Bacterial Agents, Gonorrhea. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, Spanish Ministry of Science and Innovation, WHO.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

MDR and XDR Neisseria gonorrhoeae strains remain major public health concerns internationally, and quality-assured global gonococcal antimicrobial resistance (AMR) surveillance is imperative. The WHO global Gonococcal Antimicrobial Surveillance Programme (GASP) and WHO Enhanced GASP (EGASP), including metadata and WGS, are expanding internationally. We present the phenotypic, genetic and reference genome characteristics of the 2024 WHO gonococcal reference strains (n = 15) for quality assurance worldwide. All superseded WHO gonococcal reference strains (n = 14) were identically characterized. Material and Methods The 2024 WHO reference strains include 11 of the 2016 WHO reference strains, which were further characterized, and four novel strains. The superseded WHO reference strains include 11 WHO reference strains previously unpublished. All strains were characterized phenotypically and genomically (single-molecule PacBio or Oxford Nanopore and Illumina sequencing).

Results

The 2024 WHO reference strains represent all available susceptible and resistant phenotypes and genotypes for antimicrobials currently and previously used (n = 22), or considered for future use (n = 3) in gonorrhoea treatment. The novel WHO strains include internationally spreading ceftriaxone resistance, ceftriaxone resistance due to new penA mutations, ceftriaxone plus high-level azithromycin resistance and azithromycin resistance due to mosaic MtrRCDE efflux pump. AMR, serogroup, prolyliminopeptidase, genetic AMR determinants, plasmid types, molecular epidemiological types and reference genome characteristics are presented for all strains.

Conclusions

The 2024 WHO gonococcal reference strains are recommended for internal and external quality assurance in laboratory examinations, especially in the WHO GASP, EGASP and other GASPs, but also in phenotypic and molecular diagnostics, AMR prediction, pharmacodynamics, epidemiology, research and as complete reference genomes in WGS analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neisseria gonorrhoeaeGenome, BacterialAnti-Bacterial AgentsGonorrheaMicrobial Sensitivity TestsPhenotypeHumansWorld Health OrganizationWhole Genome SequencingGenotypeDrug Resistance, BacterialQuality Assurance, Health CareReference Standards

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Faculty of Medicine and Health, WHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laboratory for STIs, Microbiology, Örebro University, Örebro, Sweden.
  • Institute for Global Health, University College London (UCL), London, UK.
  • Joint Research Unit 'Infection and Public Health', FISABIO-University of Valencia, Institute for Integrative Systems Biology (I2SysBio), Valencia, Spain.
  • CIBERESP, ISCIII, Madrid, Spain.
  • Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.
  • Hanoi Medical University, National Hospital of Dermatology and Venereology, Hanoi, Vietnam.

ORCID-Profile: Magnus Unemo, Ismael Maatouk

Förderung

  • World Health Organization
  • Spanish Ministry of Science and Innovation
  • WHO
  • Conselleria de Sanitat Universal i Salut Pública

Zitieren

APA

Unemo, M., Sánchez-Busó, L., Golparian, D., Jacobsson, S., Shimuta, K., Lan, P. T., Eyre, D. W., Cole, M., Maatouk, I., Wi, T., & Lahra, M. M. (2024). The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains—phenotypic, genetic and reference genome characterization. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae176

Vancouver

Unemo M, Sánchez-Busó L, Golparian D, Jacobsson S, Shimuta K, Lan PT, et al. The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains—phenotypic, genetic and reference genome characterization. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae176

BibTeX
@article{Unemo2024,
  author = {Unemo, Magnus and Sánchez-Busó, Leonor and Golparian, Daniel and Jacobsson, Susanne and Shimuta, Ken and Lan, Pham Thi and Eyre, David W and Cole, Michelle and Maatouk, Ismael and Wi, Teodora and Lahra, Monica M},
  title = {The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains—phenotypic, genetic and reference genome characterization},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  doi = {10.1093/jac/dkae176}
}
Kostenlos starten →